In vitro properties of BAL30072, a novel siderophore sulfactam with activity against multiresistant gram-negative bacilli.
about
"Stormy waters ahead": global emergence of carbapenemases10 x '20 Progress--development of new drugs active against gram-negative bacilli: an update from the Infectious Diseases Society of AmericaNew β-Lactamase Inhibitors in the ClinicGlycosyltransferases and Transpeptidases/Penicillin-Binding Proteins: Valuable Targets for New AntibacterialsInsights into Newer Antimicrobial Agents Against Gram-negative BacteriaAntimicrobial Drugs in Fighting against Antimicrobial ResistanceHealthcare-associated infections, infection control and the potential of new antibiotics in development in the USAStructural basis for effectiveness of siderophore-conjugated monocarbams against clinically relevant strains of Pseudomonas aeruginosaTrojan Horse Antibiotics-A Novel Way to Circumvent Gram-Negative Bacterial Resistance?Targeting Antibiotic ResistanceAntibiotics in the clinical pipeline at the end of 2015.Anticipating the Unpredictable: A Review of Antimicrobial Stewardship and Acinetobacter InfectionsAntibiotics and bacterial resistance in the 21st century.Carbapenemase-producing Klebsiella pneumoniae.LpxC inhibitors as new antibacterial agents and tools for studying regulation of lipid A biosynthesis in Gram-negative pathogens.Investigational antimicrobial agents of 2013.Clinically relevant Gram-negative resistance mechanisms have no effect on the efficacy of MC-1, a novel siderophore-conjugated monocarbam.The evolving role of chemical synthesis in antibacterial drug discovery.In vitro activity of BAL30072 against Burkholderia pseudomallei.Protein variants form a system of networks: microdiversity of IMP metallo-beta-lactamases.Iron acquisition in the cystic fibrosis lung and potential for novel therapeutic strategies.Targeting iron assimilation to develop new antibacterials.Pharmacodynamic Profiling of a Siderophore-Conjugated Monocarbam in Pseudomonas aeruginosa: Assessing the Risk for Resistance and Attenuated EfficacyPreparation of 3-benzyloxy-2-pyridinone functional linkers: Tools for the synthesis of 3,2-hydroxypyridinone (HOPO) and HOPO/hydroxamic acid chelators.Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemasesCarbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensionsIn Vitro Antimicrobial Activity of a Siderophore Cephalosporin, S-649266, against Enterobacteriaceae Clinical Isolates, Including Carbapenem-Resistant Strains.Permeability Barrier of Gram-Negative Cell Envelopes and Approaches To Bypass It.Pipeline of Known Chemical Classes of Antibiotics.β-Lactam Antibiotics Renaissance.Biscatecholate-monohydroxamate mixed ligand siderophore-carbacephalosporin conjugates are selective sideromycin antibiotics that target Acinetobacter baumanniiNovel β-lactamase inhibitors: a therapeutic hope against the scourge of multidrug resistanceA kinetic analysis of the inhibition of FOX-4 β-lactamase, a plasmid-mediated AmpC cephalosporinase, by monocyclic β-lactams and carbapenemsNew β-lactam antibiotics and β-lactamase inhibitors.Global spread of drug-resistant Acinetobacter baumannii: molecular epidemiology and management of antimicrobial resistance.Inhaled antibiotics for gram-negative respiratory infections.Will new antimicrobials overcome resistance among Gram-negatives?Exploiting bacterial iron acquisition: siderophore conjugates.Siderophore conjugates.β-Lactamase inhibitors: a review of the patent literature (2010 - 2013).
P2860
Q21131125-F0EE8BB4-D765-43F5-ABC1-2FB52DF5614EQ24601746-3E2E1A8A-0D27-457E-8993-F966FB406960Q26747150-6E9581CE-E907-4899-BD82-5FCB5C721E51Q26749531-52751354-1487-4D33-8C50-DA1B0D959F38Q26751255-665981A4-7961-45D7-A204-2DDBBD6EB0D1Q26752527-037B1046-06AB-4722-ACC9-C083CD968000Q26995305-2A8994DF-EA05-4EED-85D1-837F724CC8CFQ27666204-B3E795B6-4AF6-46DE-B64B-90823DC4DEAAQ28067116-CE1BDC5E-EC6B-49B9-8C6D-715458692187Q28078130-2EDF3046-1501-41E3-807C-B64F23A5363FQ30249262-AC16EC42-0841-495F-A5AF-4144F58CABF5Q33732524-E3EDF9D8-5C6F-4B22-B7DD-7167C451564EQ34156349-28A0B8C7-F736-4B5D-BFAA-B3BD3FFDA653Q34201937-2087309A-9570-4F30-87A5-41C2C1617BE1Q34334699-A23FEA07-6E83-45E6-9E0C-DD1D0FB42449Q34375204-769ADE98-B80F-4F56-9BE3-8F31F94B8931Q34425933-38D78CAD-95BE-42C9-8AD3-7D024EA02BD5Q34427652-BAF98C58-077F-4E55-B9A9-E528A9D35A3EQ35072096-9B658D79-C43E-4A3D-9D70-F544A9E225EDQ35205265-96246ABB-AD8C-435E-A421-F2B5F14A4B89Q35862783-14B6B0EE-7106-4E97-B372-FA902957C03EQ36211648-C8CACF08-4A1D-4DD1-B576-60D395465C6BQ36290620-B16D2EB3-5884-4139-954F-A51377377951Q36333948-C1138033-BF45-4AFD-906E-5C941299B192Q36357629-FD22BEB7-C481-4379-AF4C-ACF477450AD5Q36361921-484A4FF7-126B-44F2-9D50-33B44022D65DQ36571892-ED2C5A51-4902-4DC2-A0A8-627C9131BA10Q36611416-2D174AAB-EC33-4D96-8377-D644FAAE1975Q36683409-CC1C626E-15F5-42AC-8959-EFE35F263DDEQ36683689-99451F6D-F432-4FFB-9FCD-E09D931F14F3Q36949581-090690AC-E94D-4A1B-B884-4D3EA3C4A300Q37411475-F3A050B4-E24B-4DD8-87A2-51740CBC2415Q37579796-3B95C73E-4207-49F4-91DF-FB143E89D54DQ37788685-37D13112-C84B-4EAD-8217-764FB74270CAQ37869910-0F383537-6480-41B8-B733-0426BAAD3CBEQ37937558-FD83B0E5-2427-44DD-B5B6-20ED21D8E545Q37942654-23861F7E-AAAA-4948-9F0C-B22D70EDEDF7Q37990947-6801047C-ECCB-404C-BB8B-11D8854BF19DQ38076456-DC8DE73D-4B04-44E4-8D2A-754C810E2569Q38130715-2BA92251-20C2-4CBB-8B14-99D46472A03A
P2860
In vitro properties of BAL30072, a novel siderophore sulfactam with activity against multiresistant gram-negative bacilli.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
In vitro properties of BAL3007 ...... sistant gram-negative bacilli.
@en
type
label
In vitro properties of BAL3007 ...... sistant gram-negative bacilli.
@en
prefLabel
In vitro properties of BAL3007 ...... sistant gram-negative bacilli.
@en
P2093
P2860
P356
P1476
In vitro properties of BAL3007 ...... sistant gram-negative bacilli.
@en
P2093
Clothilde Dantier
Eric Desarbre
Malcolm G P Page
P2860
P304
P356
10.1128/AAC.01525-09
P407
P577
2010-03-22T00:00:00Z